Volume 1 Issue 4
The future of exercise therapy for people with intermittent claudication?
National Institute for Health and Care Excellence (NICE) guideline 147 recommends supervised exercise therapy (SET) for all patients with intermittent claudication, consisting of 2 hours of SET per week for a 3-month period.1 This is supported by good evidence from Cochrane reviews2,3 that SET shows improvement in mean walking performance compared with home-based exercise and…
Read MoreIlio-mesenteric bypass for chronic mesenteric ischaemia where prior endovascular treatment has failed: a case series
Abstract Background: Symptomatic chronic mesenteric ischaemia is a rare but debilitating disease, and its diagnosis is often delayed by the time taken to rule out underlying malignancy or other abdominal pathology. Once diagnosed, definitive revascularisation should not be delayed to avoid future bowel infarction. There is no consensus on the best treatment option, but most…
Read MoreResearch priorities for vascular wounds: results of the Vascular Society GBI/James Lind Alliance Priority Setting Process
Background In the UK, approximately 3.8 million people live with a wound at an estimated cost of £8.3 billion per year to the NHS, with this figure expected to rise in the future.1,2 Additionally, complications like delayed healing, infection and deterioration of other comorbidities are known to have a detrimental impact on patients’ quality of…
Read MoreDoes the level of encouragement affect 6-minute walk test performance in patients with intermittent claudication? A protocol for a randomised multicentre controlled trial
Introduction Peripheral artery disease (PAD) is characterised by atherosclerotic lesions of the arteries in the lower limbs, resulting in a reduction of blood flow.1 Globally, it is estimated that 236 million people are living with PAD, with the number of cases increasing by 24% from 2000 to 2010.2,3 A classic symptom of PAD is intermittent…
Read More- « Previous
- 1
- 2
